Breaking: Avricore Health Poised for Breakthrough Year, UK Market Expansion Accelerates
Avricore Health Inc. Reports Strong Financial Performance for 2024
VANCOUVER, British Columbia - Avricore Health Inc. (TSXV: AVCR) has announced its financial results for the year ended December 31, 2024, showcasing significant growth and expansion.
Annual Financial Highlights
- Total revenue increased by 37% year-over-year, reaching $4,785,711
- Gross profit surged by 56%, climbing to $1,880,306
Fourth Quarter Performance
- Revenue grew by 5% year-over-year to $1,421,076
- Gross profit increased by 18% to $589,930
The company highlighted its strategic expansion, including the launch and growth of HealthTab™ in North East London, demonstrating continued market penetration and business development.
These results underscore Avricore Health's commitment to driving growth and delivering value to shareholders.